Download full-text PDF

Source
http://dx.doi.org/10.1521/ijgp.2012.62.1.143DOI Listing

Publication Analysis

Top Keywords

suzanne cohen's
4
cohen's 2011
4
2011 paper
4
paper "coming
4
"coming senses
4
senses application
4
application somatic
4
somatic psychology
4
psychology group
4
group psychotherapy"
4

Similar Publications

Objective: Knowing the prevalence of mental health difficulties in young children is critical for early identification and intervention. In the current study, we examine the agreement among three different data sources estimating the prevalence of diagnoses for attention deficit hyperactivity disorder (ADHD) and emotional disorders (i.e.

View Article and Find Full Text PDF

Background: Primary care settings like federally qualified health centers (FQHC) are optimal locations to identify individuals with substance use disorders (SUD) and link them to SUD treatment, yet successful linkage has proven difficult. Recovery management checkups for primary care (RMC-PC) is a promising method for increasing linkage to care, engagement in treatment, and reducing substance use.

Methods: Participants (n = 266) who received screening, brief intervention, and referral to treatment (SBIRT) at four FQHC sites and needed SUD treatment were randomized to receive SBIRT only or SBIRT+RMC-PC.

View Article and Find Full Text PDF
Article Synopsis
  • Language accommodation is essential for providing effective interventions to ethnic minorities with limited English, exemplified by adapting the Savvy Caregiver Program for Korean American dementia caregivers.
  • The study involved two groups of 13 Korean American caregivers, where their depressive symptoms were evaluated before, right after, and six months after participating in the program led by Korean-speaking trainers.
  • Results showed a significant decrease in depressive symptoms post-intervention that continued at the six-month mark, indicating that delivering programs in participants' native languages can enhance therapeutic benefits for linguistic minorities.
View Article and Find Full Text PDF
Article Synopsis
  • Belantamab mafodotin (belamaf) is a new treatment for patients with relapsed/refractory multiple myeloma (RRMM), targeting myeloma cells and enhancing immune response.
  • The DREAMM-2 trial tested belamaf in heavily pretreated patients, revealing an overall response rate (ORR) of 32% to 35%, with median progression-free survival (PFS) of 2.8 to 3.9 months and overall survival (OS) of 14 to 15.3 months.
  • The treatment demonstrated a manageable safety profile, with common side effects including keratopathy and thrombocytopenia, while also maintaining or
View Article and Find Full Text PDF

Oxidised IL-33 drives COPD epithelial pathogenesis ST2-independent RAGE/EGFR signalling complex.

Eur Respir J

September 2023

Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK

Background: Epithelial damage, repair and remodelling are critical features of chronic airway diseases including chronic obstructive pulmonary disease (COPD). Interleukin (IL)-33 released from damaged airway epithelia causes inflammation its receptor, serum stimulation-2 (ST2). Oxidation of IL-33 to a non-ST2-binding form (IL-33) is thought to limit its activity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!